by Ginger Taylor, MS
Among the technologies discussed in the paper, are "Self-Spreading Vaccines." Vaccines that only need be given to a portion of the population, and are then become communicable between individuals, like a virus. Page 47 of the document reads in part:
"Self-spreading vaccines—also known as transmissible or self-propagating vaccines—are genetically engineered to move through populations in the same way as communicable diseases, but rather than causing disease, they confer protection. The vision is that a small number of individuals in the target population could be vaccinated, and the vaccine strain would then circulate in the population much like a pathogenic virus. These vaccines could dramatically increase vaccine coverage in human or animal populations without requiring each individual to be inoculated. This technology is currently aimed primarily at animal populations.”
“There are 2 main types of self-spreading vaccines: recombinant vector vaccines and live viral vaccines. recombinant vector vaccines combine the elements of a pathogenic virus that induce immunity (removing the portion that causes disease) with a transmissible viral vector.”
“Self-spreading vaccines have already been used to protect wild rabbits from myxomatosis and to control Sin Nombre virus in rodent populations.”
“In the event of a grave public health threat, self-spreading vaccines could potentially be used to broadly inoculate human populations. Like the approach in animals, only a small number of vaccinated individuals would be required in order to confer protection to a larger susceptible population, thus eliminating the need for mass vaccination operations, including PODs."
Covid-19 vaccines approved in the US and Europe included the Pfizer and Moderna mRNA vaccines, as well as the Janssen (Johnson & Johnson) and AstraZenica. The mechanism of these products is inject mRNA or DNA to force the cells of the individual to produce the spike protein, in the belief that the spike protein itself was not harmful in itself.